Find Duplicates among the PubMed, EMBASE, and Cochrane Library Databases in Systematic Review

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Qi, Xingshun ^a,b   Yang, Man ^a   Ren, Weirong ^a   Jia, Jia ^a   Wang, Juan ^b   Han, Guohong ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 463 Hospital of Chinese PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDD CHIARI SYNDROME; COCHRANE LIBRARY; DATA BASE; EMBASE; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MEDLINE; PORTAL VEIN THROMBOSIS; PREVALENCE; PUBLISHING; SEARCH ENGINE; SYSTEMATIC REVIEW (TOPIC);

BUDD-CHIARI SYNDROME; DUPLICATE PUBLICATION AS TOPIC; HUMANS; PORTAL VEIN; PUBMED; REVIEW LITERATURE AS TOPIC; THROMBOSIS;

EID: 84882598022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071838     Document Type: Article

References (13)

1. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535.
2. Cochrane Handbook for Systematic Reviews of Interventions. In: Higgins JPT, Green S, editors. Version 5.1.0 ed. Available: http://handbook.cochrane.org/. Accessed 2013 Jul 11.
3. Cook DJ, Greengold NL, Ellrodt AG, Weingarten SR, (1997) The relation between systematic reviews and practice guidelines. Ann Intern Med 127: 210-216.
4. Cook DJ, Mulrow CD, Haynes RB, (1997) Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126: 376-380.
5. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG, (2007) Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4: e78.
6. Qi X, De Stefano V, Wang J, Bai M, Yang Z, et al. (2013) Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol 28: 432-442.
7. Qi X, Wu F, Ren W, He C, Yin Z, et al. (2013) Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost 109: 878-884.
8. Qi X, Chen H, Han G, (2013) Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sci 346: 38-44.
9. Qi X, Yang Z, Bai M, Shi X, Han G, et al. (2011) Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther 33: 1087-1103.
10. Qi X, He C, Han G, Yin Z, Wu F, et al. (2013) Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 28: 148-152.
11. Qi X, Zhang C, Han G, Zhang W, He C, et al. (2012) Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 27: 1036-1043.
12. Qi X, Ren W, Liu L, Yang Z, Yang M, et al. (2013) Prevalence of covert duplicate publications in Budd-Chiari syndrome papers in China: a systematic analysis. Am J Med 126: 633-639.
13. von Elm E, Poglia G, Walder B, Tramer MR, (2004) Different patterns of duplicate publication: an analysis of articles used in systematic reviews. JAMA 291: 974-980.